银屑病的生物治疗新进展

万方数据

万方数据

万方数据

银屑病的生物治疗新进展

作者：李红， 周澜华， LI Hong， ZHOU Lan-hua

作者单位：李红,LI Hong(天津市长征医院,天津,300021)， 周澜华,ZHOU Lan-hua(空军航空医学研究所附属医院,北京,100089)

刊名：

中国皮肤性病学杂志

英文刊名：THE CHINESE JOURNAL OF DERMATOVENEREOLOGY

年，卷(期)：2010,24(9)

1.Berger JR;Houff SA;Major EO Monoclonal antibodies and progressive multifocal leukoencephalopathy 2009(06)

2.Leonardi C;Menter A;Hamilton T Efalizumab:results of a 3-year continuous dosing study for the

long-term control of psoriasis 2008(05)

3.Griffiths CE The immunological basis of psoriasis 2003(Suppl 2)

4.Goffe B;Papp K;Gratton D An integrated analysis of thirteen trials summarizing the long-term

safety of alefacept in psoriasis patients who have received up to nine courses of therapy[外文期刊] 2005(12)

5.Krueger GG;Papp KA;Stough DB A randomized,double-blind,placebo-controlled phase Ⅲ study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis[外文期刊] 2002(06)

6.Lebwohl M;Christophers E;Langley R An international,randomized,doubleblind,placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis 2003(06)

7.Panayi GS Immunology of psoriasis and psoriatic arthritis 1994(02)

8.Di Cesare A;Di Meglio P;Nestle FO The IL-23/Th17 axis in the immunopathogenesis of psoriasis

2009(06)

9.Austin LM;Ozawa M;Kikuchi T The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines,interferon-gamma,interleukin-2,and tumor necrosis factor-alpha,defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients 1999(05)

10.Sfikakis PP The first decade of biologic TNF antagonists in clinical practice:lessons

learned,unresolved issues and future directions 2010

11.Leonardi CL;Kimball AB;Papp KA Efficacy and safety of ustekinumab,a human interleukin-12/23 monoclonal antibody,in patients with psoriasis:76-week results from a randomised,double-

blind,placebo-controlled trial 2008(9625)

12.Krueger GG;Langley RG;Leonardi C A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis 2007(06)

13.Mossner R;Reich K Management of severe psoriasis with TNF antagonists.Adalimumab,etanereept and infliximab 2009

14.Tyring S;Gottlieb A;Papp K Etanercept and clinical outcomes,fatigue,and depression in

psoriasis:double-blind placebo-controlled randomised phase Ⅲ trial[外文期刊] 2006(9504)